CURE - Oncology & Cancer News for Patients & Caregivers
WEBSwimsuit Model Reveals Ovarian Cancer, Hockey Pro Shares Diagnosis and More. CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
Pluvicto Improves Survival Without Progression in Certain Patients …
WEBOct 23, 2023 · Pluvicto improved progression-free survival in certain patients with prostate cancer, recent research showed. Treatment with Pluvicto (177-Lu-PSMA-617) improved the duration of time when a patient’s disease did not progress with a favorable safety profile in patients with metastatic castration-resistant prostate cancer (mCRPC) who were taxane ...
What Patients Should Know About Radiation Treatment for
WEBJul 25, 2024 · Radiopharmaceuticals, defined by the National Cancer Institute as drugs that contain radioactive substances, are at the forefront of treating patients with prostate cancer, as one radiation oncologist explained in an interview with CURE®. “The newest addition to the arsenal of treatments that we can use is Pluvicto [ (lutetium Lu 177 ...
Long-Term Follow-Up Shows Keytruda Continues to Improve
WEBFeb 1, 2021 · Keytruda (pembrolizumab) continued to demonstrate a clinically meaningful improvement in overall and progression-free survival, compared with docetaxel, in patients with previously treated, PD-L1–positive advanced non-small cell lung cancer (NSCLC) after more than five years of follow-up, according to results from the phase 2/3 KEYNOTE-010 study presented at the 2020 World Conference on Lung ...
GO2 For Lung Cancer | Advocacy Groups - Curetoday
WEBMay 30, 2024 · GO2 is at the forefront of everything that’s happening in lung cancer. We’re the go-to for one-on-one assistance, supportive connections, screening and treatment information, and finding the best care close to home. We’re the place to go to learn about the latest research and special initiatives that increase survivorship. We’re the source for improving health policies and leading ...
Keytruda Has Received Nearly 40 FDA Approvals. How Does It Work?
WEBJan 25, 2024 · An expert explains how immunotherapy works. The Food and Drug Administration (FDA) recently approved Keytruda (pembrolizumab) plus chemoradiotherapy (CRT) for the treatment of patients with stages 3 to 4A cervical cancer. The first approval of an anti-programmed death receptor-1 (PD-1) therapy in combination with chemoradiotherapy for this ...
Love Lost: The Effects of Cancer on Marriage and Relationships
WEBOct 28, 2021 · A cancer diagnosis also can have a practical impact, negatively affecting job security, finances, basic family dynamics and more. “It can be very difficult to navigate,” Corbett says. Receiving a diagnosis of cancer also can have a devastating emotional impact on the caregiving spouse or partner.
How I Used Turkey Tail Mushrooms Alongside Cancer Treatment
WEBJan 8, 2024 · Turkey tail is a shelf mushroom, named that because of the way they grow on dead and decaying trees like little rows of shelves. Because of its positive effects on the immune system. Studies, such as one published in 2023 in the journal, Cureus, show that use of the mushroom improved outcomes among patients who use it …
‘Life Is Never the Same Again’: Cancer Survivors Describe the Most ...
WEBJan 26, 2022 · From mental impacts such as “scanxiety” and post-traumatic stress disorder to difficulties returning to work/dating and long-term physical side effects like memory issues, several cancer survivors shared the hardest part about survivorship.
FDA Approves Tivdak for Metastatic/Recurrent Cervical Cancer
WEBSep 20, 2021 · The FDA approved Tivdak (tisotumab vedotin-tftv) for previously treated recurrent or metastatic cervical cancer that progressed after chemotherapy treatment, according to Seagen and Genmab, the manufacturer of the drug. Tivdak is the first-ever antibody drug conjugate – a type of targeted treatment –approved for …